Abstract
Survival and growth of infectious organisms in the face of the immune response mounted by their immunocompetent hosts is made possible through one of two strategies: one is to outrun rejection by fast replication and/or mutation, as observed in some bacterial or viral infections; the other is to impair development or expression of immunity so as to evade the deleterious consequences of the host’s counter-attack. Indeed, it is now recognized that in most infections, it is the infectious organism, that determines whether or not to allow itself to be rejected by immune effectors. This is clearly the case of parasites which in general induce chronic infections and are thus confronted for months and often years with the immune response that they have to maintain within limits compatible with both their own survival and that of their mammalian hosts. This leads in many instances to the refined elaboration in these organisms of a complex network of processes allowing them to escape the defence mechanisms of their host. Such a complexity gives the expression of immunity in parasitic diseases a dynamic aspect reflecting the permanent balance between effector and regulatory mechanisms (Capron and Dessaint, in press).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amiri P, Locksley RM, Parslow TG, Sadick M, Rector E, Ritter D, Mc Kerrow JH, (1992) Nature 356:604–607
Auriault C, Joseph M, Tartar A, Bout D, Tonnel AB, Capron A (1985) Int J Immunopharmacol 7:73–79
Butterworth AE, Bensted-Smith R, Capron A, Duiton PR, Dunne DW, Grzych JM, Kariaki HC, Khalife J, Koech D, Muyambi M, Ouma JH, arap Siongok JK, Sturrock RF (1987) Parasitology 94:281–300
Butterworth AE, Vadas MA, Martz E, Sher A (1979) J Immunol 122:1314–1321
Capron A, Capron M, Joseph M, Dissous C, Auriault C (1984) New approaches to vaccine development, In: Bell R, Torrigiani G (eds) Schwabbe and Co Ag, Basel, p 460
Capron A, Dessaint JP (1985) Ann Rev Immunol 3:455–476
Capron A, Dessaint JP (in press) Adv Neuroimmunol
Capron M, Tomassini M, Van der Vorst E, Kusnierz JP, Papin JP, Capron A (1988) Cr Acad Sc Immunol 307:397–402
Dunne D, Butterworth AE, Fulford AJC, Kariuki HC, Langley JG, Ouma JH, Capron A, Pierce RJ, Sturrock RF (1992) Eur J Immunol 22:1483–1494
Duvaux-Miret O, Capron A (1991) Adv Neuroimmunol 1:41–57
Duvaux-Miret O, Dissous C, Gautron JP, Pattou E, Kordon C, Capron A (1990) New Biol 2:93–99
Duvaux-Miret O, Stefano GB, Smith EM, Dissous C, Capron A (1992) Proc Natl Acad Sci USA 89:778–781
Grzych JM, Capron M, Bazin H, Capron A (1982) J Immunol 129:2739–2743
Grzych JM, Capron M, Dissous C, Capron A (1984) J Immunol 133:998–1004
Grzych JM, Grezel D, Xu CB, Neyrinck JL, Capron M, Ouma JH, Butterworth AE, Capron A (in press) J Immunol
Grzych JM, Pearce EJ, Cheever A, Caulada ZA, Caspar P, Heiny S, Lewis F, Sher A (1991) J Immunol 146:1322–1327
Hagan P, Blumenthal UJ, Dunne D, Simpson AJG, Wilkins HA (1991) Nature 349–243
Johnson HM, Smith EM, Torres BA, Blalock JE (1982) Proc Natl Acad Sci USA 79:4171–4174
Johnson HW, Torres BA, Smith EM, Dion LD, Blalock JE (1984) J Immunol 132: 246–250
Khalife J, Capron M, Capron A Grzych JM, Butterworth AE, Dunne DW, Ouma JH (1986) J Exp Med 164:1626–1640
Khalife J, Dunne DW, Richardson BA, Mazza G, Thorne KJ, Capron A, Butterworth AE (1989) J Immunol 142:4422–4427
Mazingue C, Stadler B, Quatannens B, Capron A, De Weck A (1986) Int Archs Allergy Appl Immunol 80:347–354
Pearce E, Appleton J (in press) Parasitol Today
Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A (1991) J Exp Med 173:159–166
Pearce EJ, Sher A (1991) Exp Parasitol 73:110–116
Rihet P, Demeure CE, Bourgeois A, Prata A, Dessein AJ (1991) Eur J Immunol 21:2679–2686
Sher A, Hall BF, Vadas MA (1978) J Exp Med 148:46–52
Shipp MA, Stefano GB, D’Adamio L, Switzer SN, Howard FD, Sinisterra J, Scharrer B, Reinherz E (1990) Nature 347:394–396
Smith EM, Hughes TK, Leung MK, Stefano GB (1991) Adv. Neuroimmunol. 1:7–16
Stefano GB, Leung MK, Zhao X, Scharrer B (1989) Proc Natl Acad Sci USA 86:626–630
Stefano GB, Smith DE, Smith D, Hughes TK (in press) MSH can deactivate both TNF stimulated and spontaneously active immunocytes In: Boer H, Maat A (eds) Molluscan Neurobiology, Elsevier North Holland, Amsterdam
Torpier G, Capron A, Ouaïssi MA (1979) Nature 278:447–449
Van Epps DE, Mason MM (1990) Modulation of leukocyte migration by alphamelanocyte stimulating hormone In: Florey E, Stefano G (eds) Comparative Neuropeptide Pharmacology, Manchester University Press, UK p 335
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Capron, M., Duvaux-Miret, O., Capron, A. (1993). Escape Mechanisms in Schistosomiasis. In: Gergely, J., et al. Progress in Immunology Vol. VIII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-51479-1_87
Download citation
DOI: https://doi.org/10.1007/978-3-642-51479-1_87
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-51481-4
Online ISBN: 978-3-642-51479-1
eBook Packages: Springer Book Archive